Intervacc is trading 12.3% down at €0.08 today, driven primarily by stock-specific volatility and low liquidity in the absence of clear news catalysts.
- There are no new company announcements, earnings reports, or regulatory decisions pointing to a specific cause for the decline.
- The broader biotech sector is currently trading higher, suggesting the move is isolated to this thinly traded small-cap name rather than sector-wide pressure.